Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peterhouse Capital, formerly known as Peterhouse Corporate Finance, was a London-based investment bank and corporate broker that specialized in the small and mid-cap growth sectors. The firm provided a wide range of financial services, including mergers and acquisitions (M&A) advisory, initial public offerings (IPOs), and secondary fundraisings for companies listed on the London Stock Exchange and the Aquis Growth Market. While operating as a sector-agnostic advisor, Peterhouse maintained a significant focus on the healthcare and life sciences industries, supporting numerous biotech and medical technology firms with capital raises and regulatory guidance. In October 2025, the firm merged its capital markets business with Novum Securities to form AlbR Capital, effectively ceasing its independent operations. The legacy of Peterhouse continues through the newly formed entity, which remains a key player in the UK's growth capital markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peterhouse Corporate Finance.